These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8597941)

  • 21. Pharmacogenetics of cystic fibrosis treatment.
    Carter SC; McKone EF
    Pharmacogenomics; 2016 Aug; 17(13):1453-63. PubMed ID: 27490265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.
    Odolczyk N; Zielenkiewicz P
    Int J Biochem Cell Biol; 2014 Jul; 52():39-46. PubMed ID: 24735712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cystic fibrosis transmembrane regulator potentiators as promising cystic fibrosis therapies.
    Antoniu SA
    Expert Opin Investig Drugs; 2011 Mar; 20(3):423-5. PubMed ID: 21303308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cystic fibrosis foundation opens drug discovery lab.
    Trivedi BP
    Science; 2016 Sep; 353(6305):1194-5. PubMed ID: 27634505
    [No Abstract]   [Full Text] [Related]  

  • 25. Status of gene therapy for cystic fibrosis lung disease.
    Boucher RC
    J Clin Invest; 1999 Feb; 103(4):441-5. PubMed ID: 10021450
    [No Abstract]   [Full Text] [Related]  

  • 26. PharmGKB summary: very important pharmacogene information for CFTR.
    McDonagh EM; Clancy JP; Altman RB; Klein TE
    Pharmacogenet Genomics; 2015 Mar; 25(3):149-56. PubMed ID: 25514096
    [No Abstract]   [Full Text] [Related]  

  • 27. [Trends in the treatment of cystic fibrosis].
    Rossi G
    Recenti Prog Med; 1999; 90(7-8):380-2. PubMed ID: 10429516
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonstop treatment of cystic fibrosis.
    Dietz HC; Hamosh A
    Nat Med; 1996 Jun; 2(6):608-9. PubMed ID: 8640540
    [No Abstract]   [Full Text] [Related]  

  • 29. Discovery heralds new approach to the treatment of cystic fibrosis.
    Lowe JA
    J Med Chem; 2014 Dec; 57(23):9774-5. PubMed ID: 25384240
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting nonsense-mediated cystic fibrosis: is it premature to stop now?
    O'Sullivan BP
    Lancet Respir Med; 2014 Jul; 2(7):509-11. PubMed ID: 24836206
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding screen for cystic fibrosis transmembrane conductance regulator correctors finds new chemical matter and yields insights into cystic fibrosis therapeutic strategy.
    Hall JD; Wang H; Byrnes LJ; Shanker S; Wang K; Efremov IV; Chong PA; Forman-Kay JD; Aulabaugh AE
    Protein Sci; 2016 Feb; 25(2):360-73. PubMed ID: 26444971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis: bench to bedside 2003.
    Rubin BK
    Can Respir J; 2003 Apr; 10(3):161-4. PubMed ID: 12712228
    [No Abstract]   [Full Text] [Related]  

  • 33. Cystic Fibrosis Papers of the Year 2016.
    Doull I
    Paediatr Respir Rev; 2018 Mar; 26():10-12. PubMed ID: 28539217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel pharmacologic therapies for cystic fibrosis.
    Zeitlin PL
    J Clin Invest; 1999 Feb; 103(4):447-52. PubMed ID: 10021451
    [No Abstract]   [Full Text] [Related]  

  • 35. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [New therapies for cystic fibrosis targeting the CFTR gene or the CFTR protein].
    Hubert D; Bui S; Marguet C; Colomb-Jung V; Murris-Espin M; Corvol H; Munck A
    Rev Mal Respir; 2016 Oct; 33(8):658-665. PubMed ID: 26806675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A breath of fresh air.
    Rowe SM; Clancy JP; Sorscher EJ
    Sci Am; 2011 Aug; 305(2):68-73. PubMed ID: 21827128
    [No Abstract]   [Full Text] [Related]  

  • 38. CFTR mutations and cystic fibrosis.
    Prescrire Int; 2013 Oct; 22(142):232. PubMed ID: 24298580
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction by antitumoral drugs of proteins that functionally complement CFTR: a novel therapy for cystic fibrosis?
    Lallemand JY; Stoven V; Annereau JP; Boucher J; Blanquet S; Barthe J; Lenoir G
    Lancet; 1997 Sep; 350(9079):711-2. PubMed ID: 9291908
    [No Abstract]   [Full Text] [Related]  

  • 40. Cystic fibrosis. Difficulties of gene therapy.
    McCray PB
    Lancet; 2001 Dec; 358 Suppl():S19. PubMed ID: 11784568
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.